These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18321229)

  • 1. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Benjamin DK; Bradley J; Guidos RJ; Jones RN; Murray BE; Bonomo RA; Gilbert D;
    Clin Infect Dis; 2013 Jun; 56(12):1685-94. PubMed ID: 23599308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
    Hanson KE; Banerjee R; Doernberg SB; Evans SR; Komarow L; Satlin MJ; Schwager N; Simner PJ; Tillekeratne LG; Patel R;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S314-S320. PubMed ID: 37843119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel classes of antibiotics or more of the same?
    Coates AR; Halls G; Hu Y
    Br J Pharmacol; 2011 May; 163(1):184-94. PubMed ID: 21323894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability barriers of Gram-negative pathogens.
    Zgurskaya HI; Rybenkov VV
    Ann N Y Acad Sci; 2020 Jan; 1459(1):5-18. PubMed ID: 31165502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Gram-negative-selective antibiotic that spares the gut microbiome.
    Muñoz KA; Ulrich RJ; Vasan AK; Sinclair M; Wen PC; Holmes JR; Lee HY; Hung CC; Fields CJ; Tajkhorshid E; Lau GW; Hergenrother PJ
    Nature; 2024 Jun; 630(8016):429-436. PubMed ID: 38811738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics in the clinical pipeline as of December 2022.
    Butler MS; Henderson IR; Capon RJ; Blaskovich MAT
    J Antibiot (Tokyo); 2023 Aug; 76(8):431-473. PubMed ID: 37291465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).
    Averbuch D; Cordonnier C; Livermore DM; Mikulska M; Orasch C; Viscoli C; Gyssens IC; Kern WV; Klyasova G; Marchetti O; Engelhard D; Akova M;
    Haematologica; 2013 Dec; 98(12):1836-47. PubMed ID: 24323984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.
    Boucher HW; Ambrose PG; Chambers HF; Ebright RH; Jezek A; Murray BE; Newland JG; Ostrowsky B; Rex JH;
    J Infect Dis; 2017 Jul; 216(2):228-236. PubMed ID: 28475768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.
    Fasciano AC; Shaban L; Mecsas J
    EcoSal Plus; 2019 Feb; 8(2):. PubMed ID: 30706846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Antibacterial Candidates with New Modes of Action.
    Butler MS; Vollmer W; Goodall ECA; Capon RJ; Henderson IR; Blaskovich MAT
    ACS Infect Dis; 2024 Jul; ():. PubMed ID: 39018341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities.
    Di Maio A; Olleik H; Courvoisier-Dezord E; Guillier S; Neulat-Ripoll F; Haudecoeur R; Bolla JM; Casanova M; Cavalier JF; Canaan S; Pique V; Charmasson Y; Baydoun E; Hijazi A; Perrier J; Maresca M; Robin M
    Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-Active Antibacterial Agents Based on Calix[4]arene Derivatives: Synthesis and Biological Evaluation.
    Fang S; Dang YY; Li H; Li H; Liu J; Zhong R; Chen Y; Liu S; Lin S
    Front Chem; 2022; 10():816741. PubMed ID: 35211455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriocins: Potential for Human Health.
    Huang F; Teng K; Liu Y; Cao Y; Wang T; Ma C; Zhang J; Zhong J
    Oxid Med Cell Longev; 2021; 2021():5518825. PubMed ID: 33936381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health.
    Roblin C; Chiumento S; Jacqueline C; Pinloche E; Nicoletti C; Olleik H; Courvoisier-Dezord E; Amouric A; Basset C; Dru L; Ollivier M; Bogey-Lambert A; Vidal N; Atta M; Maresca M; Devillard E; Duarte V; Perrier J; Lafond M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Aminoglycoside Resistance Genes and Molecular Characterization of a Novel Gene,
    Zhu X; Li P; Qian C; Liu H; Lin H; Zhang X; Li Q; Lu J; Lin X; Xu T; Zhang H; Hu Y; Bao Q; Li K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruminococcin C, a promising antibiotic produced by a human gut symbiont.
    Chiumento S; Roblin C; Kieffer-Jaquinod S; Tachon S; Leprètre C; Basset C; Aditiyarini D; Olleik H; Nicoletti C; Bornet O; Iranzo O; Maresca M; Hardré R; Fons M; Giardina T; Devillard E; Guerlesquin F; Couté Y; Atta M; Perrier J; Lafond M; Duarte V
    Sci Adv; 2019 Sep; 5(9):eaaw9969. PubMed ID: 31579822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of drug-resistant bacteria and rational use of clinical antimicrobial agents.
    Zhou C; Chen X; Wu L; Qu J
    Exp Ther Med; 2016 Jun; 11(6):2229-2232. PubMed ID: 27313667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model.
    Tan S; Gan C; Li R; Ye Y; Zhang S; Wu X; Yang YY; Fan W; Wu M
    Int J Nanomedicine; 2015; 10():1045-59. PubMed ID: 25709431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.
    Islam A; Da Silva JG; Berbet FM; da Silva SM; Rodrigues BL; Beraldo H; Melo MN; Frézard F; Demicheli C
    Molecules; 2014 May; 19(5):6009-30. PubMed ID: 24824136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.